FINWIRES · TerminalLIVE
FINWIRES

Enliven Therapeutics Insider Sold Shares Worth $263,577, According to a Recent SEC Filing

By

Benjamin Hohl, CFO, on June 17, 2026, sold 6,018 shares in Enliven Therapeutics (ELVN) for $263,577. Following the Form 4 filing with the SEC, Hohl has control over a total of 51,000 common shares of the company, with 51,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000188276426000005/xslF345X05/form4-06222026_090607.xml

Related Articles